Hospice campaigners getting 'no answers' over centre's future
Campaigners trying to save an inpatient unit at hospice said they were still waiting for answers from the charity's bosses, almost a year since it closed.The 26-bed inpatient unit at Marie Curie in Woolton, Liverpool, closed last July because of a shortage in specialised nursing staff.A public meeting was held last night by the Save Our Hospice group, which is urging the charity to provide more clarity over the unit's future.A Marie Curie representative thanked campaigners for their "continued passion and support" and said staff, volunteers and the local community "will be the first to hear about any developments and decisions".
"We are shouting and screaming for support here and we are being ignored," campaigner Kate said."We are asking where is the money going? Where is the support? Why is this happening? We are not having answers, and we want to know why."If there isn't any money then tell us because we would like to then obviously try and support there being some money."We want to fundraise, we want to do whatever it is we can. What are the issues, because we would like to help."A Marie Curie North West representative said: "We know the local community is concerned and many are finding the current situation difficult."We would like to thank the group for inviting us to give an update at this meeting and for their continued passion and support."Moving forward, we would hope to be able to participate in these meetings together with NHS Cheshire & Merseyside Integrated Care Board (ICB), who have responsibility for commissioning end of life care."The charity said it would post regular updates on its website and said staff, volunteers and the local community "will be the first to hear about any developments and decisions as and when they happen".
Listen to the best of BBC Radio Merseyside on Sounds and follow BBC Merseyside on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Sky News
37 minutes ago
- Sky News
Millions to receive NHS screening invitations and appointment reminders on their phones
Appointment reminders, invitations to health screenings and test results will now be received by patients on their phones. The government says moving to a more digital-focused NHS will mean 50 million fewer letters need to be sent out by the health service, saving an estimated £200m over the next three years. Instead, under the new plans, millions of people will be notified about appointments and other important notices via the NHS app on their phone or digital device. The app is set to become the go-to method for the NHS to communicate with people, the Department of Health and Social Care said. The changes will be backed by more than £50m investment. It will see a predicted 270 million messages sent through the app this year, an increase of around 70 million on the last financial year, the government announced. Wes Streeting has said this is all about modernising, as the NHS "feels so 20th century". The health secretary said: "The fact that people still get letters through the front door, sometimes multiple letters about the same appointment... The NHS has been stuck in the mud when it comes to the everyday technology we use to organise our lives. And that's why what we're doing with the NHS app is really exciting." Mr Streeting said the app will make using the NHS more convenient, and give patients more control, while saving money. He said these funds can then be invested back into the health service, to bolster things such as frontline care. Using the NHS app should be 'as joyful as Netflix' The modernisation of the NHS will also lead to fewer missed appointments, and therefore save money that way too, it is hoped. In 2023/24, there were around eight million missed appointments in elective care and almost one in three people missed a screening appointment. Currently, around 20 million people have opted in to receive messages from the NHS app. 4:01 Pushed on how the government will ensure that nobody is left behind, Mr Streeting said: "If someone like me is booking my appointment through the app because that's what I prefer to do, [then] that's freeing up a phone line for someone who wants to get through and talk to a person." He added that greater use of the app will give people more choice in "how you want to organise your care". The cabinet minister also made a bold comparison, saying he wishes that the NHS app is as enjoyable as using streaming giant Netflix. He said: "The NHS app actually has more subscribers than Netflix. It would be a really wonderful thing if using the NHS app felt - if not as joyful - almost as joyful as using Netflix." Other features in the pipeline - though not yet available - include being able to add appointments to phone calendars and request help from local GPs on the app. Faster log in methods, such as using Face ID, are also planned.
Daily Mail
an hour ago
- Daily Mail
Statins almost halve the risk of death in patients critically ill with sepsis
Taking statins can improve the chances of surviving sepsis by 40 per cent, a trial has found. Sepsis can occur when the body's immune system overreacts to an infection and attacks its own organs. It is notoriously difficult to spot because the telltale symptoms, such as a fever and muscle pain, can be easily mistaken for signs of a common cold or other infection. Statins lower cholesterol to prevent heart attacks and strokes and are taken by around 5 million adults in the UK. But experts say they have other benefits, including reducing inflammation and fighting bacteria that can ultimately lead to sepsis. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent. The study compared survival rates of sepsis patients given statins and those who were not during a hospital stay. It found the pills reduced the risk of death for those critically ill with the condition by 39 per cent (file image) In intensive care, 14.3 per cent of 6,000 sepsis patients given statins died within 28 days, compared with 23.4 per cent of 6,000 patients who were not. For those no longer in a critical condition, 11 per cent given statins died compared to 19 per cent who were not. Dr Caifeng Li, of Tianjin Medical University General Hospital in China and the study's author said: 'These results suggest that statins may provide a protective effect and improve clinical outcomes for patients with sepsis.' Researchers believe the drugs may help with sepsis by helping to combat bacteria directly, reducing the toll infection takes on the body. Earlier this year another study found the pills could also slash dementia risk – even in patients who don't have high cholesterol. The sepsis study, published in the journal Frontiers in Immunology, was based on data from thousands of patients at an Israeli hospital over a decade. Dr Ron Daniels, founder and chief executive of the UK Sepsis Trust, said: 'This study supports calls for a large, multi-country, randomised control trial. 'Anything which might reduce the burden of a condition which claims one in five lives worldwide needs to be rigorously explored.' Sepsis is known as the 'silent killer'. For every hour of delay in treatment, a patient's chance of dying increases 8 per cent. If caught early, it can be treated with antibiotics and fluids. Symptoms include slurred speech or confusion, shivering or muscle pain, passing no urine in a day, severe breathlessness and mottled or discoloured skin. Blood test to spot Alzheimer's early A Blood test for Alzheimer's can accurately detect the disease early, a study suggests. The test was 95 per cent accurate in identifying people with memory problems. It also scored 82 per cent for specificity, which means it was highly accurate in ruling out people without dementia. The study, published in the journal Alzheimer's and Dementia, found proteins amyloid beta 42/40 and p-tau217 in blood plasma can be examined to diagnose the condition. The study was carried out on more than 500 people in an outpatient memory clinic. The blood test has already been approved by the Food and Drug Administration regulator in the US.
Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE Exposed: 'DIY Ozempic' sellers putting lives at risk by peddling super cheap but super dangerous self-mixing weight loss drugs in booming black market
Cheap 'Do It Yourself Ozempic' is being sold across Britain in a booming black market that puts lives at risk, a Daily Mail investigation has found. Scores of dealers based in the UK and China are using social media to openly advertise their cut-price illegal fat jabs to vulnerable people.
